Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

Bibliographic Details
Main Authors:	Diekstra, Meta H. M., Liu, Xiaoyan, Swen, Jesse J., Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H. J., Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I., Guchelaar, Henk-Jan
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643117/

Similar Items

Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
by: de Wit, Djoeke, et al.
Published: (2014)

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
by: Xu, C-F, et al.
Published: (2015)

Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma
by: Prior, Celia, et al.
Published: (2014)

Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma
by: Shamran, Haidar A., et al.
Published: (2015)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
by: Hutson, T E, et al.
Published: (2014)

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
by: Lam, Siu W, et al.
Published: (2016)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib
by: Tazi, El Mehdi, et al.
Published: (2011)

A Case of Metastatic Adamantinoma That Responded Well to Sunitinib
by: Liman, Andrew D., et al.
Published: (2016)

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
by: Beuselinck, B, et al.
Published: (2013)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
by: Ordu, Çetin, et al.
Published: (2016)

Impact of Single Nucleotide Polymorphism in IL-4, IL-4R Genes and Systemic Concentration of IL-4 on the Incidence of Glioma in Iraqi Patients
by: Shamran, Haidar A., et al.
Published: (2014)

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
by: Shibasaki, Noboru, et al.
Published: (2015)

Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population
by: Yu, Pengli, et al.
Published: (2012)

Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population
by: Milano, Mariana, et al.
Published: (2016)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
by: Motzer, R J, et al.
Published: (2013)

Combining radiotherapy with sunitinib: lessons (to be) learned
by: Kleibeuker, Esther A., et al.
Published: (2015)

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence
by: Kloth, Jacqueline S. L., et al.
Published: (2015)

Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series
by: Lipplaa, Astrid, et al.
Published: (2016)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
by: Swen, Jesse J, et al.
Published: (2007)

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
by: Molina, Ana M., et al.
Published: (2010)

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
by: Chara, Luis, et al.
Published: (2011)

Retraction: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
by: Tazi, El Mehdi, et al.
Published: (2011)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
by: Gilabert, M, et al.
Published: (2013)

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
by: Morizane, Shuichi, et al.
Published: (2012)

Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
by: Yildiz, Ibrahim, et al.
Published: (2014)

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
by: Tielen, Ronald, et al.
Published: (2012)

Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
by: Pander, Jan, et al.
Published: (2015)

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.
by: Lissoni, P., et al.
Published: (1998)

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
by: DePrimo, Samuel E, et al.
Published: (2007)

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
by: Rini, Brian I., et al.
Published: (2011)

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
by: Donskov, Frede, et al.
Published: (2015)

IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity.
by: Ebina, N., et al.
Published: (1990)

Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs
by: Neves, Fabiana, et al.
Published: (2015)

Gestire il cambiamento: Renzi, il PD e il nuovo “collateralismo”
by: Rossana Sampugnaro
Published: (2017-06-01)

The Roles of IL-2, IL-7, and IL15 Ligands in B Cells Development from Cord Blood Mononuclear Cells
by: Aliyari, Z, et al.
Published: (2015)

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
by: Gore, M E, et al.
Published: (2015)

The role of cytokines in seizures: interleukin (IL)-1β, IL-1Ra, IL-8, and IL-10
by: Youn, Youngah, et al.
Published: (2013)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
by: Papadopoulos, Jordan, et al.
Published: (2014)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
by: Farahani, Rahim, et al.
Published: (2014)

The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
by: Chognard, Gaëlle, et al.
Published: (2014)